84 related articles for article (PubMed ID: 12890369)
1. Correlation of pulmonary functions of COPD patients to those of their first-degree children.
Lu B; He Q
Chin Med J (Engl); 2003 Jul; 116(7):991-5. PubMed ID: 12890369
[TBL] [Abstract][Full Text] [Related]
2. [Pulmonary function in first generation children of chronic obstructive pulmonary disease (COPD) patients: assessment of related predicting factors].
Lu B; He Q; Chen Q; Huang X; Li J
Zhonghua Yi Xue Za Zhi; 2002 Aug; 82(16):1136-9. PubMed ID: 12425829
[TBL] [Abstract][Full Text] [Related]
3. [Risk factors of chronic obstructive pulmonary disease in patients with chronic bronchitis].
Xie G; Cheng X; Xu X
Zhonghua Yi Xue Za Zhi; 2001 Nov; 81(22):1356-9. PubMed ID: 11930627
[TBL] [Abstract][Full Text] [Related]
4. [The importance of the at risk COPD patients (Stage 0) and clinical differences].
Kömüs N; Tertemiz KC; Sevinç C
Tuberk Toraks; 2008; 56(4):382-9. PubMed ID: 19123073
[TBL] [Abstract][Full Text] [Related]
5. Peripheral arterial disease: an underestimated aetiology of exercise intolerance in chronic obstructive pulmonary disease patients.
Castagna O; Boussuges A; Nussbaum E; Marqueste L; Brisswalter J
Eur J Cardiovasc Prev Rehabil; 2008 Jun; 15(3):270-7. PubMed ID: 18446087
[TBL] [Abstract][Full Text] [Related]
6. Nasal symptoms, airway obstruction and disease severity in chronic obstructive pulmonary disease.
Hurst JR; Kuchai R; Michael P; Perera WR; Wilkinson TM; Wedzicha JA
Clin Physiol Funct Imaging; 2006 Jul; 26(4):251-6. PubMed ID: 16836700
[TBL] [Abstract][Full Text] [Related]
7. Decline in FEV1 in relation to incident chronic obstructive pulmonary disease in a cohort with respiratory symptoms.
Lindberg A; Larsson LG; Rönmark E; Jonsson AC; Larsson K; Lundbäck B
COPD; 2007 Mar; 4(1):5-13. PubMed ID: 17364672
[TBL] [Abstract][Full Text] [Related]
8. Systemic CD4+ T-cell activation is correlated with FEV1 in smokers.
Glader P; von Wachenfeldt K; Löfdahl CG
Respir Med; 2006 Jun; 100(6):1088-93. PubMed ID: 16246539
[TBL] [Abstract][Full Text] [Related]
9. Genetic epidemiology of severe, early-onset chronic obstructive pulmonary disease. Risk to relatives for airflow obstruction and chronic bronchitis.
Silverman EK; Chapman HA; Drazen JM; Weiss ST; Rosner B; Campbell EJ; O'DONNELL WJ; Reilly JJ; Ginns L; Mentzer S; Wain J; Speizer FE
Am J Respir Crit Care Med; 1998 Jun; 157(6 Pt 1):1770-8. PubMed ID: 9620904
[TBL] [Abstract][Full Text] [Related]
10. Genetics of chronic obstructive pulmonary disease.
Silverman EK
Novartis Found Symp; 2001; 234():45-58; discussion 58-64. PubMed ID: 11199103
[TBL] [Abstract][Full Text] [Related]
11. Characteristics of a population of COPD patients identified from a population-based study. Focus on previous diagnosis and never smokers.
Miravitlles M; Ferrer M; Pont A; Luis Viejo J; Fernando Masa J; Gabriel R; Jiménez-Ruiz CA; Villasante C; Fernández-Fau L; Sobradillo V
Respir Med; 2005 Aug; 99(8):985-95. PubMed ID: 15950139
[TBL] [Abstract][Full Text] [Related]
12. Familial aggregation in chronic obstructive pulmonary disease: use of the loglinear model to analyze intermediate environmental and genetic risk factors.
Khoury MJ; Beaty TH; Tockman MS; Self SG; Cohen BH
Genet Epidemiol; 1985; 2(2):155-66. PubMed ID: 3876967
[TBL] [Abstract][Full Text] [Related]
13. [The investigation of the relationship between Leptin-insulin resistance and pulmonary function in patients with chronic obstructive pulmonary disease with acute exacerbation].
Pan HY; Lu XZ; Wang DX; Zeng Y; Zhong HB
Zhongguo Wei Zhong Bing Ji Jiu Yi Xue; 2007 Sep; 19(9):519-21. PubMed ID: 17767817
[TBL] [Abstract][Full Text] [Related]
14. CT and functional respiratory tests. Evaluation of efficacy of bronchodilator therapy in chronic obstructive pulmonary disease (COPD).
Costantini AM; Sallustio G; Misciasci T; Corbo GM; Valente S; Pirronti T; Marano P
Radiol Med; 2004; 108(1-2):17-27. PubMed ID: 15269687
[TBL] [Abstract][Full Text] [Related]
15. [Expressions of and the effect of smoking on vascular endothelial growth factor and induced nitric oxide synthase in lung tissues of chronic obstructive pulmonary disease patients].
Huo JM; Chen JY; Kong YJ; Shi YZ
Zhonghua Jie He He Hu Xi Za Zhi; 2007 Aug; 30(8):573-6. PubMed ID: 17988548
[TBL] [Abstract][Full Text] [Related]
16. Proposal for a multidimensional staging system for chronic obstructive pulmonary disease.
Celli BR; Calverley PM; Rennard SI; Wouters EF; Agusti A; Anthonisen N; Macnee W; Jones P; Pride N; Rodriguez-Roisin R; Rossi A; Wanner A
Respir Med; 2005 Dec; 99(12):1546-54. PubMed ID: 16291077
[TBL] [Abstract][Full Text] [Related]
17. [The study of interleukin-13 gene promoter polymorphism in patients with chronic obstructive pulmonary disease].
He B; Zhao MW; Ning LD; Jiang L; Yao WZ
Zhonghua Jie He He Hu Xi Za Zhi; 2004 Aug; 27(8):529-32. PubMed ID: 15388001
[TBL] [Abstract][Full Text] [Related]
18. Evidence of lower alteration of expiratory volume in patients with airflow limitation in the immediate period after lobectomy.
Varela G; Brunelli A; Rocco G; Jiménez MF; Salati M; Gatani T
Ann Thorac Surg; 2007 Aug; 84(2):417-22. PubMed ID: 17643609
[TBL] [Abstract][Full Text] [Related]
19. Chronic obstructive pulmonary disease and body mass index in five Latin America cities: the PLATINO study.
Montes de Oca M; Tálamo C; Perez-Padilla R; Jardim JR; Muiño A; Lopez MV; Valdivia G; Pertuzé J; Moreno D; Halbert RJ; Menezes AM;
Respir Med; 2008 May; 102(5):642-50. PubMed ID: 18314321
[TBL] [Abstract][Full Text] [Related]
20. [Clinical course of the ventilatory function in COPD: analytical study of 160 cases].
Battikh MH; Ben Sayah MM; Joobeur S; Naouar R; Maatallah A; Rouatbi N; Ben Salem K; El Kamel A
Tunis Med; 2004 Aug; 82(8):735-41. PubMed ID: 15532768
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
